Related Experiment Video
Updated: Oct 14, 2025
Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
Transcriptomic and Network Meta-Analysis of Frontotemporal Dementias
Virginie Bottero1, Fahed Alrafati1, Jose A Santiago2
1Center for Neurodegenerative Diseases and Therapeutics, Chicago Medical School, Discipline of Cellular and Molecular Pharmacology, Rosalind Franklin University of Medicine and Science, North Chicago, IL, United States.
Frontotemporal dementia (FTD) shows distinct gene expression patterns in familial versus sporadic forms. Understanding these differences, particularly Wnt and MAPK signaling pathways, may reveal new therapeutic targets for young-onset dementia.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Frontotemporal lobar degeneration (FTLD), or frontotemporal dementia (FTD), is a common cause of young-onset dementia.
- FTD presents with executive dysfunction, behavioral changes, speech issues, and movement disorders.
- Familial and sporadic forms exist, with GRN and C9orf72 mutations being common genetic causes.
Purpose of the Study:
- To compare the transcriptomes of sporadic and familial FTD in key brain regions.
- To identify specific genes and pathways involved in both forms of FTD.
- To explore potential therapeutic strategies for FTD.
Main Methods:
- Transcriptome analysis of cerebellum, frontal cortex, hippocampus, and Brodmann's area 8 in FTD patients.
- Meta-analysis to identify commonly dysregulated genes across brain regions.
- Comparison of gene expression patterns between familial and sporadic FTD.
Main Results:
- Most dysregulated gene expression was observed in the frontal cortex (familial) and Brodmann's area 8 (sporadic).
- Meta-analysis identified 50 dysregulated genes in familial FTD and 95 in sporadic FTD across at least three brain regions.
- Familial FTD genes were associated with Wnt signaling, while sporadic FTD genes centered on MAPK signaling.
Conclusions:
- Distinct molecular pathways (Wnt vs. MAPK signaling) differentiate familial and sporadic FTD.
- Valproic acid and other agents may hold therapeutic potential for FTD.
- This study highlights key similarities and differences between FTD subtypes.
